ALIGNMENT HEALTHCARE INC (ALHC)

US01625V1044 - Common Stock

13.5  +1.62 (+13.64%)

After market: 13.5 0 (0%)

Full estimates are only available for subscribed users, you can see which data is available below.

Subscribed users also see more surprise data, now it is restricted to 4 quarters.

Examples of complete estimate data are available for MSFT and AAPL.

Registered users have access to more data. Please register or login for additional estimates and surprises .

Yearly Revenue, EBIT, EBITDA and EPS Analyst Estimates
2021 2022 2023 2024 2025 2026 2027 2028
Revenue
YoY % growth
1.168B
21.75%
1.434B
22.81%
1.824B
27.15%
2.726B
49.48%
3.523B
29.24%
4.315B
22.48%
5.172B
19.86%
6.367B
23.11%
EBITDA
YoY % growth
-162.07M
-1,695.18%
-111.11M
31.44%
-106.149M
4.46%
-3.318M
96.87%
42.39M
1,377.75%
83.81M
97.71%
129.64M
54.68%
N/A
EBIT
YoY % growth
-178.1M
-3,260.38%
-128.6M
27.79%
-127.817M
0.61%
-110.241M
13.75%
-83.626M
24.14%
-40.02M
52.14%
N/AN/A
Operating Margin
-15.25%-8.97%-7.01%-4.04%-2.37%-0.93%N/AN/A
EPS
YoY % growth
-1.13-0.82
27.43%
-0.78
4.88%
-0.70
10.55%
-0.51
26.61%
-0.40
21.07%
0.13
132.81%
0.44
230.77%

All data in USD

Quarterly Revenue, EBIT, EBITDA and EPS Analyst Estimates
Q4 / 24 Q1 / 25 Q2 / 25 Q3 / 25 Q4 / 25 Q1 / 26 Q2 / 26 Q3 / 26 Q4 / 26
EPS
Q2Q % growth
-0.19
25.95%
-0.22
13.15%
-0.08
39.47%
-0.09
36.51%
-0.17
9.48%
-0.19
13.87%
-0.03
56.79%
-0.06
31.15%
-0.12
26.96%
Revenue
Q2Q % growth
686.92M
47.60%
868.75M
38.20%
900.25M
32.14%
890.8M
28.65%
870.52M
26.73%
1.07B
23.17%
1.118B
24.19%
1.101B
23.60%
1.068B
22.69%
EBITDA
Q2Q % growth
-2.231M
88.98%
-4.47M
87.26%
20.895M
459.39%
20.792M
2,740.44%
5.262M
335.83%
3.958M
188.55%
34.911M
67.08%
33.646M
61.82%
16.415M
211.95%
EBIT
Q2Q % growth
-27.004M
35.57%
-31.514M
23.34%
-8.735M
52.48%
-10.417M
46.64%
-22.684M
16.00%
-22.777M
27.72%
7.426M
185.01%
5.739M
155.09%
-11.009M
51.47%

All data in USD

Recent Earnings VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
-0.14
22.22%
-0.140.003.21%
Q2 2024
Q2Q % growth
-0.13
13.33%
-0.150.0211.63%
Q1 2024
Q2Q % growth
-0.25
-25.00%
-0.23-0.02-10.04%
Q4 2023
Q2Q % growth
-0.25
19.35%
-0.23-0.02-10.30%
Q3 2023
Q2Q % growth
-0.18
18.18%
-0.190.013.30%
Q2 2023
Q2Q % growth
-0.15
-150.00%
-0.220.0732.72%
Q1 2023
Q2Q % growth
-0.20
13.04%
-0.260.0622.89%
Q4 2022
Q2Q % growth
-0.31
-14.81%
-0.30-0.01-2.28%
Q3 2022
Q2Q % growth
-0.22
15.38%
-0.250.0312.22%
Q2 2022
Q2Q % growth
-0.06
76.00%
-0.260.2077.19%
Q1 2022
Q2Q % growth
-0.23
34.29%
-0.250.028.34%
Q4 2021
Q2Q % growth
-0.27 -0.300.0311.40%
Q3 2021
Q2Q % growth
-0.26 -0.18-0.08-48.48%
Q2 2021
Q2Q % growth
-0.25 -0.11-0.14-122.82%
Q1 2021
Q2Q % growth
-0.35 -0.19-0.16-80.60%
Recent Revenue VS Estimates Surprises (USD)
PeriodReportedEstimateDifferenceSurprise
Q3 2024
Q2Q % growth
692.433M
51.61%
675.35M17.083M2.53%
Q2 2024
Q2Q % growth
681.286M
47.34%
650.4M30.886M4.75%
Q1 2024
Q2Q % growth
628.601M
43.14%
607.03M21.571M3.55%
Q4 2023
Q2Q % growth
465.387M
28.63%
453.49M11.897M2.62%
Q3 2023
Q2Q % growth
456.709M
26.76%
453.14M3.569M0.79%
Q2 2023
Q2Q % growth
462.379M
26.16%
447.81M14.569M3.25%
Q1 2023
Q2Q % growth
439.155M
27.11%
440M-845K-0.19%
Q4 2022
Q2Q % growth
361.8M
21.29%
347.94M13.86M3.98%
Q3 2022
Q2Q % growth
360.3M
22.76%
340.07M20.23M5.95%
Q2 2022
Q2Q % growth
366.5M
18.61%
344.73M21.77M6.32%
Q1 2022
Q2Q % growth
345.5M
29.35%
339.13M6.37M1.88%
Q4 2021
Q2Q % growth
298.3M
22.61%
274.97M23.33M8.48%
Q3 2021
Q2Q % growth
293.5M
17.73%
281.07M12.43M4.42%
Q2 2021
Q2Q % growth
309M
26.48%
272.61M36.39M13.35%
Q1 2021
Q2Q % growth
267.1M
18.92%
255.92M11.18M4.37%
Q4 2020
Q2Q % growth
243.3M
27.78%
%
Q3 2020
Q2Q % growth
249.3M
33.17%
%
Q2 2020
Q2Q % growth
244.3M
23.88%
%
Q1 2020
Q2Q % growth
224.6M
23.34%
%
EPS and Revenue Revisions
Next Q (1 month) Next Q (3 month) Next Year (1 month) Next Year (3 month)
EPS0% 1.89% 0% -1.8%
Revenue0% 7.05% 0% 1.6%